首页 | 本学科首页   官方微博 | 高级检索  
     


The treatment of ankylosing spondylitis
Authors:K.J. Scalapino  J.C. Davis Jr.
Affiliation:(1) Division of Rheumatology, The University of California San Francisco, 533 Parnassus Avenue, Box 0633, Room U383, San Francisco, CA 94143, USA. jdavis@medicine.ucsf.edu, US
Abstract:
Ankylosing spondylitis is an inflammatory disorder affecting the axial skeleton and periphery. Symptoms can often be debilitating. Current therapy for the disease include physical therapy, non-steroidal anti-inflammatory drugs (NSAIDS, anti-rheumatic disease modifying drugs (DMARDS), and the newly developed biologic agents targeting tumor necrosis factor alpha (TNF-α). This paper will provide a comprehensive review of these treatments which focusing on evidence based medicine for the daily clinical practice of rheumatology. Received: 31 December 2002 / Accepted: 15 January 2003 Correspondence to J.C. Davis Jr.
Keywords:Ankylosing spondylitis  Medical therapies  NSAIDS  Physical therapy  Sulfasalazine  Pamidronate  Thalidomide  Methotrexate  Biologic agents  TNF
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号